LH

Labcorp Holdings Inc.

Healthcare
283.36 up +1.42 +0.50% Pre-Market
2026-07-17 • USD

Key Metrics

Market Cap 23.24B
EV 29.43B
Shares Out 82.00M
Revenue (ttm) 14.14B
Net Income 941.50M
Beta
P/E
Forward P/E
EPS (ttm) $11.29
P/S 1.65
P/B 2.67
P/FCF 16.85
P/C 12.86
EV/Sales 2.08
EV/EBITDA 13.83
ROA 4.93%
ROE 10.95%
ROIC
Gross Margin 28.83%
Oper. Margin 10.18%
Profit Margin 6.66%
Debt/Eq 0.82
LT Debt/Cap 40.06%
Quick Ratio 1.24
Current Ratio 1.73
Book/sh 106.06
Cash/sh 11.92
Div Yield 1.02%
Div TTM $2.88
Payout Ratio 25.51%
SMA20 3.18%
SMA50 6.71%
SMA200 6.0%
Volume 631,900
Avg Volume 629.40K
Rel Volume 1.0
Perf Week 2.41%
Perf Month 10.77%
Perf Quarter 5.26%
Perf Half Y 4.44%
Perf YTD 12.95%
Perf Year 16.26%
Perf 3Y 29.57%
Perf 5Y 19.17%

Factor Lens

Seasonal Performance

Dividends

Per-share amounts adjusted for stock splits.

Last Dividend $0.7200
TTM Yield 1.02%
TTM Amount $2.88
Payout Ratio 25.51%
3-Yr Growth (CAGR) 10.06%
5-Yr Growth (CAGR)

Last 12 Payouts

Period Ex-Date Amount / Share
Q1 2026 ~2026-03-31 $0.7200
Q4 2025 ~2025-12-30 $0.7200
Q3 2025 ~2025-09-30 $0.7200
Q2 2025 ~2025-06-30 $0.7200
Q1 2025 ~2025-03-31 $0.7200
Q3 2024 ~2024-09-30 $0.7200
Q2 2024 ~2024-06-30 $0.7200

Financial Trends

Revenue & Net Income

Earnings Per Share

Margins

Cash Flow

Company Overview

Labcorp Holdings Inc. is a global leader of innovative and comprehensive laboratory services that provides vital information to help doctors, hospitals, pharmaceutical companies,

Name
Labcorp Holdings Inc.
Industry
Diagnostics & Research
CEO
Adam H. Schechter · Chairman, President, and Chief Executive Officer
Employees
71,000 as of 2025-12-31
IPO Date
2018-10-18
Phone
(336) 229-1127
Address
358 South Main Street, Burlington, NC 27215
Website
http://www.labcorp.com

Key Executives

Name Title FY Pay
Peter M. Neupert Director
Paul B. Rothman, M.D. Director
Kerrii B. Anderson Director
Garheng Kong, M.D., Ph.D. Vice Chairman and Lead Independent Director
Adam H. Schechter Chairman, President, and Chief Executive Officer

Latest News